Investigating how Wnt7a helps prevent the progression of osteoarthritis
Wnt7a-Mediated Competence to Resist Osteoarthritis Progression
['FUNDING_R01'] · TUFTS UNIVERSITY BOSTON · NIH-11041076
This study is looking at why some people with risk factors for osteoarthritis don’t get the disease or have milder symptoms, focusing on a molecule called Wnt7a that might help protect joints from damage, with the hope of finding new ways to treat osteoarthritis.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TUFTS UNIVERSITY BOSTON (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-11041076 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding why some individuals with risk factors for osteoarthritis (OA) do not develop the disease or experience it less severely. It explores the role of a molecule called Wnt7a, which may help resist inflammation and joint damage associated with OA. By studying the relationship between Wnt7a levels and the severity of OA in cartilage samples, the research aims to identify mechanisms that could lead to better treatments for this debilitating condition. The approach involves analyzing human cartilage specimens to uncover how Wnt7a influences disease progression.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for osteoarthritis, such as those with joint injuries or older adults.
Not a fit: Patients who are already diagnosed with advanced osteoarthritis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that prevent or slow down the progression of osteoarthritis.
How similar studies have performed: Other research has shown promising results in understanding the role of signaling molecules in joint health, suggesting that this approach may yield valuable insights.
Where this research is happening
BOSTON, UNITED STATES
- TUFTS UNIVERSITY BOSTON — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ZENG, LI — TUFTS UNIVERSITY BOSTON
- Study coordinator: ZENG, LI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.